Skip to main content
Equibles

MRC · MERCATOR MEDICAL SPÓŁKA AKCYJNA · Financials

Use MRC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
56.7000 PLN -0.2000 (-0.35%) At close · Oct 5
Rebalance outlook locked
Market Cap
522.17M PLN
Shares
9.14M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
574.18M +5.8%
FY2025 Revenue FY2019–FY2025
Net Income
28.59M -35.9%
FY2025 Net Income FY2019–FY2025
Operating Margin
-1.2% -6.9pp
FY2025 Operating Margin FY2019–FY2025
Operating Cash Flow
37.49M +156.8%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
PLN 574.18M 542.49M 469.06M 542.51M 1.73B 1.83B 539.72M
PLN 28.78M 23.31M 22.12M 25.67M 19.31M 18.52M 17.44M
PLN -6.91M 31.1M -87.12M -181.22M 463.43M 1.05B 7.19M
PLN 1.05M 20.78M 1.1M 22.95M 8.6M 7.98M 8.91M
PLN 28.4M 35.44M -3.79M -186.22M 477.23M 1.04B 2.07M
PLN -946K -7.97M 19.04M 4.57M 32.37M 105M 4.1M
PLN 28.59M 44.63M -19.68M -189.62M 446.87M 930.19M -2.33M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2025: 386.39M in buybacks, 32.07M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current borrowings, including current portion of noncurrent borrowings 2025-12-31 PLN 65,000 ESEF Annual Report filed 2026-04-30
Current lease liabilities 2025-12-31 PLN 4,818,000 ESEF Annual Report filed 2026-04-30
Noncurrent lease liabilities 2025-12-31 PLN 18,087,000 ESEF Annual Report filed 2026-04-30
Noncurrent long-term borrowings 2025-12-31 PLN 0 ESEF Annual Report filed 2026-04-30
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.